BI Survo GLP-1 Use Update; Ionis Q3 ’26 Earnings; Lilly ATTAIN-OSA Data; November CHMP Agenda
A series of cardiometabolic-related news items has been observed from Boehringer Ingelheim, Ionis, Lilly, and EMA. Below, FENIX provides highlights and insights for the respective news items.
